Concepedia

Andreas Geissner

AG

16

Publications

670

Citations

15

H-Index

2012

Active since

Affiliations

Max Planck Institute of Colloids and Interfaces(Current)

Freie Universität Berlin

University of Alberta

University of British Columbia

Charité - Universitätsmedizin Berlin

Andreas Geissner is an author at Max Planck Institute of Colloids and Interfaces specializing in medicine, glycobiology, and natural sciences.

Top concepts

MedicineBiochemistryGlycobiologyNatural SciencesImmunologyMolecular BiologyMicrobiologyGlycoproteomicsBiomolecular EngineeringHigh-throughput Screening

Publications per year

2012–2023

16

Publications

16

Automated Synthesis of Arabinoxylan‐Oligosaccharides Enables Characterization of Antibodies that Recognize Plant Cell Wall Glycans

Deborah Schmidt, Frank Schuhmacher, Andreas Geissner et al. · Chemistry - A European Journal · 2015 · 103 citations

Microbe-focused glycan array screening platform

Andreas Geissner, Anika Reinhardt, Christoph Rademacher et al. · Proceedings of the National Academy of Sciences · 2019 · 91 citations

Bioorganic Chemistry, Glycan Binding Proteins, Glycobiology +21

SNF2 family ATPase LSH promotes phosphorylation of H2AX and efficient repair of DNA double-strand breaks in mammalian cells

Joe Burrage, Ausma Termanis, Andreas Geissner et al. · Journal of Cell Science · 2012 · 61 citations · Full text

Histone Modifications, Dna Damage, Dna Double-strand Breaks +22

A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection

Sharavathi G. Parameswarappa, Katrin Reppe, Andreas Geissner et al. · Cell chemical biology · 2016 · 57 citations · Full text

Vaccination, Vaccine Development, Immunology +9

Semisynthetic glycoconjugate vaccine candidate against <i>Streptococcus pneumoniae</i> serotype 5

Marilda P. Lisboa, Naeem Khan, Christopher E. Martin et al. · Proceedings of the National Academy of Sciences · 2017 · 52 citations · Full text

Rows per page

1–5 of 16